Showing results (21-30 of 126) with videos related to
Sort By:
Pageof 13
The Journal of Clinical Endocrinology and Metabolism|April 14, 2005
Effects of calcium supplementation on body weight and blood pressure in normal older women: a randomized controlled trialIan R Reid, Anne Horne, Barbara Mason, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 29, 2021
Bone Mineral Density and Bone Turnover 10 Years After a Single 5 mg Dose or Two 5-Yearly Lower Doses of Zoledronate in Osteopenic Older Women: An Open-Label Extension of a Randomized Controlled TrialAndrew Grey, Mark J Bolland, Anne Horne, et al.The Journal of Clinical Endocrinology and Metabolism|December 4, 2008
The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal womenAndrew Grey, Mark J Bolland, Diana Wattie, et al.Arthritis Care & Research|May 18, 2026
A return to normality: A descriptive qualitative interview study exploring the patient experience of gout flare resolutionSarah Stewart, Anne Horne, Angelo Gaffo, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 13, 2017
Duration of antiresorptive activity of zoledronate in postmenopausal women with osteopenia: a randomized, controlled multidose trialAndrew Grey, Mark J Bolland, Anne Horne, et al.Annals of the Rheumatic Diseases|January 22, 2013
Tendon involvement in the feet of patients with gout: a dual-energy CT studyNicola Dalbeth, Ramanamma Kalluru, Opetaia Aati, et al.The Journal of Clinical Endocrinology and Metabolism|February 1, 2007
The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trialAndrew Grey, Mark Bolland, Greg Gamble, et al.The Journal of Rheumatology|July 15, 2026
Do people with tophaceous gout require more allopurinol for good clinical outcomes? Analysis of two randomized controlled trials with allopurinol dose escalationLisa K Stamp, Anne Horne, Jill Drake, et al.The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetateTim Cundy, Ruth Ames, Anne Horne, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 14, 2013
Duration of antiresorptive effects of low-dose zoledronate in osteopenic postmenopausal women: a randomized, placebo-controlled trialAndrew Grey, Mark Bolland, Bobby Mihov, et al.Pageof 13